Correlation Among Sperm DNA Fragmentation, Genitourinary Infection by Mycoplasma in Male and the Pregnancy Outcomes After IUI in Their Partner
1 other identifier
interventional
200
0 countries
N/A
Brief Summary
Genital ureaplasmas (Ureaplasma urealyticum and Ureaplasma parvum) and genital mycoplasmas (Mycoplasma hominis and Mycoplasma genitalium) are natural inhabitants of the male urethra contaminating the semen during ejaculation. However, these microorganisms, especially Ureaplasma urealyticum (Uu) and Mycoplasma hominis (Mh), are potentially pathogenic species playing an etiologic role in both genital infections and male infertility. Despite there are many consentaneous opinions about its relationship with infertility, its correlation with sperm regular parameters is still controversially. Sperm DNA damage can negatively influence fertilization rate, embryo cleavage rate, implantation rate, pregnancy and live birth rate, and is a novel indicator for intrauterine insemination (IUI) pregnancy rate and IVF or ICSI pregnancy loss rate. Until now, there were fewer clinical researches about the relationship among Uu and/or Mh infection, sperm DNA damage, and the IUI pregnancy rate. Thus, the investigators conduct this prospective study to investigate the relationship among them.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Sep 2011
Typical duration for phase_4
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2011
CompletedFirst Submitted
Initial submission to the registry
March 9, 2012
CompletedFirst Posted
Study publicly available on registry
March 15, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedApril 10, 2013
April 1, 2013
2.3 years
March 9, 2012
April 8, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
pregnancy rate
up to 3 monthes after IUI
Secondary Outcomes (1)
sperm DNA fragmentation index (DFI)
one month before IUI
Study Arms (3)
males who were not infected by mycoplasma
ACTIVE COMPARATOR100 male patients whose spouse was going to conduct IUI, was not infected by mycoplasma.
infected by mycoplasma males
EXPERIMENTAL100 male patients whose spouse was going to conduct IUI, was infected by mycoplasma.
fertile males
NO INTERVENTION50 fertile males were chose as control samples
Interventions
Eligibility Criteria
You may qualify if:
- Male with primary sterility with or without mycoplasma infection
You may not qualify if:
- Combination with chlamydial infection
- History of using hormone or cytotoxic drugs.
- Having some other surgical diseases, such as genital tract infection or varicocele
- Having some congenital diseases, such as Klinefelter and Y chromosome deficiency
- Having some endocrine diseases, such as Kallmann, abnormality in pituitary gland, hyperthyroidism, hypercorticoidism, and so on
- Patients' spouse had some diseases that could not carry out spontaneous pregnancy, such as tubal obstruction or ovulatory failure.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Feng Panlead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- NON RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Clinical Attending Doctor
Study Record Dates
First Submitted
March 9, 2012
First Posted
March 15, 2012
Study Start
September 1, 2011
Primary Completion
December 1, 2013
Study Completion
December 1, 2013
Last Updated
April 10, 2013
Record last verified: 2013-04